Certified by Founder
Lodge
Outrun Therapeutics
start up
United Kingdom
- Dundee, Scotland
- 19/04/2024
- Seed
- $10,000,000
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
- Industry Biotechnology Research
- Website https://outruntx.com/
- LinkedIn https://www.linkedin.com/company/outrun-therapeutics/
Related People
Carolyn PorterFounder
United Kingdom -
Greater Oxford Area
25 years of leadership experience, including in the spin-out arena, having led the formation of 16 companies raising £52M cumulatively in seed financing while at Oxford University. Held Board positions in several biotech companies and formerly held Business Development roles in big pharma (Novartis) and big biotech(Chiron).
Specialties: Key skills include business development, deal negotiation and execution, strategic, market and business analysis, people management and project management.
Zero Homes | $16,800,000 | (Feb 19, 2026)
Rainfall Health | $15,000,000 | (Feb 19, 2026)
inKind | $450,000,000 | (Feb 19, 2026)
Sift Biosciences | $3,700,000 | (Feb 19, 2026)
Avantos.ai | $25,000,000 | (Feb 19, 2026)
Korsana Biosciences | $175,000,000 | (Feb 19, 2026)
Vervesemi | $10,000,000 | (Feb 19, 2026)
Efficient Computer | $60,000,000 | (Feb 19, 2026)
DG Matrix | $60,000,000 | (Feb 19, 2026)
Synchrony Medical | $5,000,000 | (Feb 19, 2026)
Dataro | $14,280,000 | (Feb 18, 2026)
The Compression Company | $3,400,000 | (Feb 18, 2026)